Blood Neurofilament Light Chain (NfL) Assay: Multiple Sclerosis

Publication Brief

Neurofilament light (NfL) is a cytoskeletal intermediate filament protein that is expressed in neurons and can be released in significant quantities following axonal damage or neuronal degeneration. NfL has been shown to be associated with multiple sclerosis (MS) and other neurodegenerative diseases. Download our flyer to learn more about the measurement of NfL with Simoa® and view recent publications demonstrating the value that ultrasensitive biomarker detection brings to MS research.

If you see this, do not fill:

Fill in the form below.

First Name *
Last Name *
Email *
Company *
What type of organization is your company? *
Country *
State *
Postal Code *
Phone
Therapeutic Area
To select multiple values, hold down the Shift or Control (PC) or Command (Mac) key.
Disease Focus
To select multiple values, hold down the Shift or Control (PC) or Command (Mac) key.
I consent

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.